Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to be a global threat since its emergence. Although several COVID-19 vaccines have become available, the prospective timeframe for achieving effective levels of vaccination across g...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wei, Shyr, Zeenat, Lo, Donald C., Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686716/
https://www.ncbi.nlm.nih.gov/pubmed/33972366
http://dx.doi.org/10.1124/jpet.121.000688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686716/
https://www.ncbi.nlm.nih.gov/pubmed/33972366
http://dx.doi.org/10.1124/jpet.121.000688

Ejemplares similares